Glyburide

Routes
Oral (PO)
Half-Life (t½)
PO: 9.7h
Formula
C23H28ClN3O5S
Molecular Weight
494 g/mol
PubChem CID
3488
Aliases
Glibenclamide, DiaBeta

Pharmacological Mechanism

Second-generation sulfonylurea — K-ATP channel closure → insulin release. Hepatically metabolized (CYP3A4); active M1 metabolite contributes to hypoglycemia in renal impairment. Beers-list problematic in elderly.

Half-Life & Elimination Curve (PO: 9.7h)

100%50%25%12.5%0%0h0×t½9.7h1×t½19.4h2×t½29.1h3×t½38.8h4×t½48.5h5×t½0×t½ (0h): 100% remaining (~0.276 mg/L)1×t½ (9.7h): 50% remaining (~0.138 mg/L)2×t½ (19.4h): 25% remaining (~68.9 µg/L)3×t½ (29.1h): 12.5% remaining (~34.4 µg/L)4×t½ (38.8h): 6.3% remaining (~17.2 µg/L)5×t½ (48.5h): 3.1% remaining (~8.61 µg/L)
Plasma (PO)t½ Decay (9.7h)
  • 0×t½0h100% (0.276 mg/L)
  • 1×t½9.7h50% (0.138 mg/L)
  • 2×t½19.4h25% (68.9 µg/L)
  • 3×t½29.1h12.5% (34.4 µg/L)
  • 4×t½38.8h6.3% (17.2 µg/L)
  • 5×t½48.5h3.1% (8.61 µg/L)
Elimination t½9.7h (PO)
Rate Constant (ke)0.0715 h⁻¹
Time to Peak (Tmax)3.63h
Est. Peak (Cmax)0.276 mg/L
Clearance (CL)1 L/h
97% Washout (5×t½)48.5h

Dosing Guidelines

Pharmacokinetic Parameters

Pathways It Modulates

Target Organ Systems

Chemical Structure & Identifiers

References